Item 8.01 Other Events.

On July 14, 2022, Vivos Therapeutics, Inc. (the "Company") issued a press release announcing that the Company has received multiple Class I clearances by the Therapeutic Goods Administration (TGA) of Australia, a Tier 1 regulatory body for multiple indications to include the treatment of snoring and obstructive sleep apnea (mild, moderate and severe) for both adults and children for its series of oral appliances.

The Company's press release relating to clearances by the Therapeutic Goods Administration (TGA) of Australia is filed as Exhibit 99.1 hereto.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
99.1            Press Release of the Company, dated July 14, 2022.
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)




2

© Edgar Online, source Glimpses